ArticleMethods in molecular biology (Clifton, N.J.)2026
Production of Antibody Fragments Suitable for 1:1, Site-Specific Labeling.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunoreagents, such antibodies, must often be functionalized before being used for a specific application, and this modification can strongly affect their biophysical characteristics. In contrast, recombinant antibody fragments can be engineered with elevated precision at selected residues to obtain customized reagents. Several alternative strategies can be used that exploit different principles and require different effort to reach this objective. Direct labeling can be obtained by fusing the antibody fragment to a fluorescent protein; otherwise, tag sequences can be appended to the binders and then these are modified by chemical or enzymatic reactions. In this contribution, a model system will be illustrated and compared with other options to illustrate what factors should be considered to choose the functionalization strategy.
Indexed as
Identifiers
42129100What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.